Page 3 - Andre Holme News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Persistent questions on whether rare but serious blood clots among those getting the AstraZeneca jab against Covid-19 are more frequent than in the general population, and what causes them if they are, have continued to undermine confidence in the beleaguered vaccine. The European Medicines Agency--which has said that benefits outweigh risks such that the vaccine should remain in use--will provide an updated assessment next week.  What serious events have been reported? The blood clots seen in a handful of people vaccinated with AstraZeneca are described by the French Medicines Agency (ANSM) ...

Concerns over very rare blood clots may lead health regulator to restrict age groups to which AstraZeneca is administered

Persistent questions on whether rare but serious blood clots among those getting the AstraZeneca jab against COVID-19 are more frequent than in the general population, and what causes them if they are, have continued to undermine confidence in the beleaguered vaccine.

Australia will continue its inoculation program with AstraZeneca PLC, health officials said on Saturday, despite a blood clotting case of a 44-year-old man who was admitted to a Melbourne hospital with clotting, just days after receiving the AstraZeneca vaccine. The UK medical regulator also said on Saturday, local time, that out of 30 people who suffered rare blood clots after receiving the AstraZeneca vaccine, seven had died. It comes as several European countries paused the jab over a potential link to blood clots. As of 31 March, The European Medicines Agency (EMA) identified 62 cases...

SEVEN people have died from blood clots after taking the AstraZeneca vaccine in the UK – but regulators have insisted the jab is safe.The medicines